Teva Can't Nix Glaxo's Asthma Patent In EPO Appeal
Teva's U.K. business has failed to convince an appeals board at the European Patent Office to upend a decision that a Glaxo Group patent for a drug combination used to treat...To view the full article, register now.
Already a subscriber? Click here to view full article